Thomas E.  Jackiewicz to Serve as Chair of Founders Board for Dr Foster International

 

April 11, 2011  |  

Thomas E. Jackiewicz, chief executive officer of UC San Diego Health System, has been elected to serve as Chair of the Founder’s Board for the Dr Foster 2011 Global Comparators Project. The project’s aim is to understand trends in global health and to drive lifesaving improvements in patient care. The Board is comprised of CEOs and leadership from 31 top-ranked hospitals in five countries.
“I am honored to serve as Chair for the Dr Foster Global Comparators Board,” said Jackiewicz. “This is a unique opportunity to connect world-class hospitals to share and compare international data, groundbreaking academics and confirmed best practices.”

Dr Foster is one of Europe’s largest medical informatics organizations. Its Founder’s Board was established to provide strategic direction to the long-term development of the Global Comparators Project. Participating countries include the United States, the UK, Italy and the Netherlands.

Thomas Jackiewicz

Thomas Jackiewicz, CEO, UC San Diego Health System

“By collaborating and intelligently comparing hospital data we will be able to develop an international system for monitoring clinical performance. We are looking for trends that rise above our local hospitals to form insights that will positively impact delivery of care,” said Jackiewicz. “Our goal is to see decreased mortality, shorter hospital stays and fewer readmissions. Our interactions will serve to inform our hospitals strategies and to inspire future research.”

Activities for the board include delivery of a methodology for directly comparing specific outcomes for small groups of patients with common characteristics in hospitals across national borders, creation of a common risk model based on effectively mapping benchmark data, and the deployment of analytical tools that allow hospitals to understand the details behind variations in performance.

Jackiewicz was appointed CEO of UC San Diego Health System in November 2009. He previously served as associate vice chancellor and chief financial officer for Health Sciences at UC San Diego, chief operating officer of Columbia University Medical Center, senior associate chair for finance and administration at the Stanford University School of Medicine, director of finance and administration for Oregon Health Sciences University and director of business and financial operations at the University of Pennsylvania Health System.

Jackiewicz has also served as the National Chair of the American Association of Medical Colleges (AAMC) Group on Business Affairs, and is a member of the Healthcare Financial Management Association and the University HealthSystem Consortium.

#  #  #

UC San Diego Health System
UC San Diego Health System, in operation since 1966, comprises UC San Diego Medical Center, Thornton Hospital, Moores Cancer Center, Shiley Eye Center, Sulpizio Cardiovascular Center and Jacobs Medical Center (opening in 2016), as well as other primary and specialty practices of UC San Diego Medical Group located throughout southern California. The only academic health system in the San Diego region, its mission is to provide excellent and compassionate patient care, advance medical discoveries, and educate the health care professionals of tomorrow. For more information, visit health.ucsd.edu

Media Contact: Jackie Carr, 619-543-6163, jcarr@ucsd.edu




Media Contact

Share This Article


Related News

9/16/2019
New technology from Cydar is allowing UC San Diego Health surgeons to repair aneurysms previously deemed inoperable.
9/10/2019
UC San Diego researchers say that measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increas ...
9/5/2019
The San Diego Center for AIDS Research (CFAR) at University of California San Diego has been awarded planning grants to help the federal government achieve its goal of reducing the number of new HIV i ...
9/3/2019
A new University of California San Diego School of Medicine study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.



Follow Us